Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Astrocytes are glial cells in the CNS that maintain brain metabolic homeostasis. Their metabolism is highly adaptable through a process called metabolic reprogramming, enabling them to support neuronal function, modulate immune responses, and contribute to neuroprotection and tissue repair. Key features include glucose uptake via GLUTs, lactate production via LDH and export via MCTs (astrocyte-neuron lactate shuttle), the pentose phosphate pathway (PPP) for NADPH production, and fatty acid/amino acid metabolism. Reprogramming is triggered by ischemia/hypoxia (increased glucose uptake, glycolysis, lactate output, PPP activity) and neurodegenerative diseases (shift toward aerobic glycolysis). Dysregulation contributes to disease progression via impaired energy supply, altered redox balance, and changes in metabolite shuttling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Astrocyte Metabolic Reprogramming.